Mississippi medical cannabis revenue up $500K as patient base grows

January 8, 2026

BILOXI, Miss. (WLOX) – Mississippi’s Medical Cannabis Program generated significant revenue growth in 2025, with tax collections increasing by half a million dollars over the previous year, according to the Mississippi State Department of Health.

The cannabis tax brought in $2.18 million, while state sales tax on cannabis products collected another $9 million.

Patient participation also grew substantially, with 66,041 active patients by the end of the year compared to 49,626 patients in 2024.

The number of active certifying practitioners stayed steady at 259, including physicians, nurse practitioners, and optometrists.

Chronic pain and PTSD remain the most common qualifying conditions for medical cannabis use. Type 2 diabetes with neurological complications is also on the rise as a qualifying condition.

The top ten qualifying conditions from the past two years are as follows:

Rank 2024 2025
1 Chronic Pain Chronic Pain
2 Post-Traumatic Stress Disorder (PTSD) Post-Traumatic Stress Disorder (PTSD)
3 Spinal Cord Disease or Severe Injury Spinal Cord Disease or Severe Injury
4 Cancer Cancer
5 Muscle Spasms Muscle Spasms
6 Long Term Use of Opiate Analgesic Type 2 Diabetes Mellitus with Neurological Complications
7 Type 2 Diabetes Mellitus with Neurological Complications Severe Nausea
8 Nausea Seizure
9 Glaucoma Pain Refractory to Appropriate Opioid Management
10 Epilepsy and Recurrent Seizures Glaucoma

Retail sales for the year totaled nearly $139 million.

Flower products were the most affordable option available to patients, with an average cost of around $22.

See a spelling or grammar error in this story? Report it to our team HERE.

 

Go to Top